hong xin 3d

TEL :+86 0769-85886566

Biological 3D printing technology gradually fire

DiSanto company was founded in 1967 by OttavioDiSanto, according to the specialized contract manufacturing department of orthopedics implants. Over the past 12 months, DiSanto sales revenue of approximately $12000000, $600000 in pre tax profit. From 2013 February onwards, DiSanto has been Arcam's strategic partner.
In September 3, 2014, the famous Swedish industrial grade 3D printer maker ArcamAB announced the acquisition of Department of orthopedics implant manufacturers of finished products of DiSantoTechnology (DiSanto). With this acquisition, Arcam will provide customers -- including the industry leading department of orthopedics and spinal implants -- 3D company provides print implants and other components.
The total amount of the purchase of $15800000, a cash payment. Arcam through the implementation of stock options issued in February 2013 to obtain cash income to pay the exchange funds.
Electron beam melting of Arcam (EBM) technology and DiSanto in the Department of orthopedics implant manufacturing field of long-term accumulation of knowledge and experience combined application will accelerate increasing material manufacturing technology in the implant industry. At the same time, according to the China 3D print network understanding, professional technology of DiSanto in implant design and production of finished parts, will be conducive to Arcam Manufacturing Department of orthopedics implants using EBM technology.
After the merger, DiSanto will become the Arcam subsidiary, the existing management team remain unchanged, continue to be responsible for company business. The acquisition is expected to be Arcam2014 years of profits of the company have a positive impact.
"With this acquisition, Arcam products will cover the entire supply chain: earlier this year, the acquisition of APC provide metal powder; ArcamAB provides EBM system and service; and the DiSanto is providing products. Therefore, the acquisition is in line with our growth strategy, it improve our technology and product portfolio, and is expected to have an immediate positive effect." The chief executive of Arcam, said MagnusRen